NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,046 | -39.2% | 3,045 | -41.2% | 0.00% | 0.0% |
| Q2 2023 | $36,260 | +158.4% | 5,180 | +142.5% | 0.00% | 0.0% |
| Q1 2023 | $14,035 | +26890.4% | 2,136 | -69.5% | 0.00% | 0.0% |
| Q4 2022 | $52 | -99.7% | 6,994 | +328.3% | 0.00% | 0.0% |
| Q3 2022 | $20,000 | +122.2% | 1,633 | +435.4% | 0.00% | – |
| Q2 2022 | $9,000 | -25.0% | 305 | -40.3% | 0.00% | – |
| Q1 2022 | $12,000 | -55.6% | 511 | +163.4% | 0.00% | -100.0% |
| Q4 2021 | $27,000 | -48.1% | 194 | -21.1% | 0.00% | 0.0% |
| Q3 2021 | $52,000 | -24.6% | 246 | -23.1% | 0.00% | 0.0% |
| Q2 2021 | $69,000 | +27.8% | 320 | +9.6% | 0.00% | 0.0% |
| Q1 2021 | $54,000 | +50.0% | 292 | -13.1% | 0.00% | 0.0% |
| Q4 2020 | $36,000 | +38.5% | 336 | +39.4% | 0.00% | -50.0% |
| Q3 2020 | $26,000 | – | 241 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |